https://www.selleckchem.com/products/yo-01027.html
The incidence of vaginal and vulvar cancer remained relatively constant at about 2/100,000. Relative 1-year survival in cervical cancer improved in all countries from low 80%s to high 80%s in the 50-year period, and 5-year survival improved also but at 20% units lower level. Survival gains were found only in patients diagnosed before age 60 years. Survival in vaginal and vulvar cancer followed the same patterns but at a few % units lower level. Cervical cancer screening appeared to have reached its limits in the Nordic countries by yea
Me gusta
Comentario
Compartir
